STAT Plus A stem cell company is touting a stroke survivors recovery. Its media blitz offers investors a mirage

STAT Plus: A stem cell company is touting a stroke survivor’s recovery. Its media blitz offers investors a mirage

A small drug maker is using the story of a stroke survivor to promote the development of an experimental stem cell therapy. But by doing so, the company has obscured…

More From BioPortfolio on "STAT Plus: A stem cell company is touting a stroke survivor’s recovery. Its media blitz offers investors a mirage"